Aktuelle Stellenangebote
Postdoctoral fellow (m/f/d) - BK-2023-3
The LIT - Leibniz Institute for Immunotherapy (foundation under civil law) researches and develops new immunotherapies for the treatment of tumours, autoimmune diseases and transplant rejections.
The LIT is seeking a highly motivated
The LIT is seeking a highly motivated
Postdoctoral fellow (m/f/d) - BK-2023-3
Kategorie: Wissenschaftliches Personal
Beschäftigungsverhältnis: Vollzeit
Gültig bis: 25.06.2023
(full time, 40.1 hours per week)
to join our Algorithmic Bioinformatics research group. The position is available starting September 1, 2023 and initially limited to two years with the possibility of
continued employment.
The Algorithmic Bioinformatics research group is a purely computational lab developing and investigating new algorithms for solving bioinformatics problems on sequencing data. The problems we address include read alignment, variant detection & genotyping, genome assembly, whole-genome alignment and more in the context of human and population genetics, immunology, cancer and other biomedical research areas.
to join our Algorithmic Bioinformatics research group. The position is available starting September 1, 2023 and initially limited to two years with the possibility of
continued employment.
The Algorithmic Bioinformatics research group is a purely computational lab developing and investigating new algorithms for solving bioinformatics problems on sequencing data. The problems we address include read alignment, variant detection & genotyping, genome assembly, whole-genome alignment and more in the context of human and population genetics, immunology, cancer and other biomedical research areas.
Responsibilities:
- Design, implement and test new algorithms for the analysis of short and long read (genome) sequencing data
- Analyze small to large-scale sequencing data sets
- Provide assistance to PhD students
- Supervise MSc students independently
- Support collaboration projects within the LIT
Requirements:
- PhD degree in Bioinformatics or a related field
- Profound understanding of sequence analysis algorithms and data structures
- Hands-on experience in high-throughput sequencing data analysis
- Good programminng skills in C++ and Python
- Strong publication record
- Excellent communication skills, both oral and written in English
We offer:
- An international cutting-edge research environment
- Possibility to visit international conferences and collaborators
- Individual development opportunities
- Flexible working hours
- Flat hierarchies and short decision-making processes
- A highly motivated and cooperative team
- Job ticket
The remuneration is based on TV-L.
The Leibniz Institute for Immunotherapy targets to increase the share of women in the workforce. Therefore, qualified female candidates are explicitly encouraged to submit their applications. Moreover, the LIT advocates for the compatibility of family and career.
Disabled applicants (m/f/d) with equal qualifications will receive preferential treatment within the recruitment procedure. Please refer to your disability status already in your application.
Please note that expenses that may arise in the context of an eventual job interview cannot be reimbursed.
For more information, please contact Birte Kehr (birte.kehr@ukr.de). We are looking forward to receiving your application including a cover letter, CV with publication list, certificates and two references. Please apply via our homepage www.rcii.de quoting the reference BK-2023-3.
The application deadline is June 25th, 2023.
The Leibniz Institute for Immunotherapy targets to increase the share of women in the workforce. Therefore, qualified female candidates are explicitly encouraged to submit their applications. Moreover, the LIT advocates for the compatibility of family and career.
Disabled applicants (m/f/d) with equal qualifications will receive preferential treatment within the recruitment procedure. Please refer to your disability status already in your application.
Please note that expenses that may arise in the context of an eventual job interview cannot be reimbursed.
For more information, please contact Birte Kehr (birte.kehr@ukr.de). We are looking forward to receiving your application including a cover letter, CV with publication list, certificates and two references. Please apply via our homepage www.rcii.de quoting the reference BK-2023-3.
The application deadline is June 25th, 2023.
Technical Assistant (BTA / MTA) (m/f/d) (SST-2023-1)
The LIT - Leibniz Institute for Immunotherapy (foundation under civil law) researches and develops new immunotherapies for the treatment of tumours, autoimmune diseases and transplant rejections.
The group of Prof. Beckhove at the Leibniz Institute for Immunotherapy (LIT) is seeking an enthusiastic
The group of Prof. Beckhove at the Leibniz Institute for Immunotherapy (LIT) is seeking an enthusiastic
Technical Assistant (BTA / MTA) (m/f/d) (SST-2023-1)
Kategorie: Wissenschaftliches Personal
Beschäftigungsverhältnis: Vollzeit
Gültig bis: 11.06.2023
full time, limited to 2 years with possibility for extension
Your Profile
We look for a highly motivated colleague that is able to work independently, and who is eager to support the lab. Being a team player as well as strong communication and organizational skills are necessary. Sufficient English skills to work in an international environment are mandatory. In addition to training in standard molecular and cellular methods such as western blot, PCR, cloning, cell culture, DNA and RNA isolation the applicant should bring experience in at least one of the following methods:
We look for a highly motivated colleague that is able to work independently, and who is eager to support the lab. Being a team player as well as strong communication and organizational skills are necessary. Sufficient English skills to work in an international environment are mandatory. In addition to training in standard molecular and cellular methods such as western blot, PCR, cloning, cell culture, DNA and RNA isolation the applicant should bring experience in at least one of the following methods:
- Immunological methods such as flow cytometry, cytokine assays, primary T cell isolation/culture
- Animal work (mouse models)
- CRISPR/Cas9 genome editing
- Virus work (biosafety level 2)
What we offer
Our lab offers the opportunity to work at the interface of immunology and cancer, which is one of the most exciting fields of recent biomedical research. We provide a dynamic and motivating working environment where you can foster your skills and get the opportunity to learn cutting-edge technologies such as CRISPR gene editing, T cell engineering, etc..
Our lab offers the opportunity to work at the interface of immunology and cancer, which is one of the most exciting fields of recent biomedical research. We provide a dynamic and motivating working environment where you can foster your skills and get the opportunity to learn cutting-edge technologies such as CRISPR gene editing, T cell engineering, etc..
- An international research environment that offers exciting and diverse opportunities
- Responsible and varied field of activity
- Flat hierarchies and short decision-making processes
- A highly motivated and cooperative team
- Individual development opportunities
- Flexible working hours
- Job ticket
The remuneration is based on TV-L.
The Leibniz Institute for Immunotherapy targets to increase the share of women in the workforce. Therefore, qualified female candidates are explicitly encouraged to submit their applications. Moreover, the LIT advocates for the compatibility of family and career.
Disabled applicants (m/f/d) with equal qualifications will receive preferential treatment within the recruitment procedure. Please refer to your disability status already in your application.
Please note that expenses that may arise in the context of an eventual job interview cannot be reimbursed.
For more information, please contact Slava Stamova (slava.stamova@ukr.de). We are looking forward to receiving your application including a cover letter, CV, certificates and two references. Please apply via our homepage www.rcii.de quoting the reference SST-2023-1.
The application deadline is June 11th, 2023.
The Leibniz Institute for Immunotherapy targets to increase the share of women in the workforce. Therefore, qualified female candidates are explicitly encouraged to submit their applications. Moreover, the LIT advocates for the compatibility of family and career.
Disabled applicants (m/f/d) with equal qualifications will receive preferential treatment within the recruitment procedure. Please refer to your disability status already in your application.
Please note that expenses that may arise in the context of an eventual job interview cannot be reimbursed.
For more information, please contact Slava Stamova (slava.stamova@ukr.de). We are looking forward to receiving your application including a cover letter, CV, certificates and two references. Please apply via our homepage www.rcii.de quoting the reference SST-2023-1.
The application deadline is June 11th, 2023.
PhD position (E13, 65 %) at the Leibniz Institute for Immunotherapy (LIT) with flexible starting date (m/f/d)
PhD position (E13, 65 %) at the Leibniz Institute for Immunotherapy (LIT) with flexible starting date (m/f/d)
Kategorie: Wissenschaftliches Personal
Beschäftigungsverhältnis: Teilzeit
Gültig bis: 25.06.2023
The LIT - Leibniz Institute for Immunotherapy (foundation under civil law) (http://www.rcii.de/en/), formerly RCI – is a biomedical research center focusing on translational immunology in the fields of cancer immunotherapy, transplant rejection and autoimmunity. The objective of the LIT is to develop innovative and efficient cellular immune therapeutics in these areas. Our own GMP laboratories and close networking with University and University Hospital offer excellent opportunities for clinical translation of novel immune cell products.
The group of Prof. Philipp Beckhove at the LIT (https://www.rcii.de/en/research/departments/department-for-interventional-immunology/about/) is looking for a highly motivated and talented PhD student to pursue cutting-edge research in the field of experimental and molecular tumor immunology and genetic T cell engineering.
The group of Prof. Philipp Beckhove at the LIT (https://www.rcii.de/en/research/departments/department-for-interventional-immunology/about/) is looking for a highly motivated and talented PhD student to pursue cutting-edge research in the field of experimental and molecular tumor immunology and genetic T cell engineering.
About the project
Our group is interested in investigating the mechanisms underlying the complex interplay between immune and malignant cells, resulting in the control and eradication of cancer. With the help of state-of-the-art methods such as long-term live cell imaging, single-cell RNA-sequencing and transcriptome analysis, and CRISPR genome editing, we aim to reveal the molecular basis of effective immune responses to malignancies. In addition, we utilize the obtained knowledge by means of genetic T cell-engineering to generate T cells that have superior anti-tumor activity.
Your task will include:
Our group is interested in investigating the mechanisms underlying the complex interplay between immune and malignant cells, resulting in the control and eradication of cancer. With the help of state-of-the-art methods such as long-term live cell imaging, single-cell RNA-sequencing and transcriptome analysis, and CRISPR genome editing, we aim to reveal the molecular basis of effective immune responses to malignancies. In addition, we utilize the obtained knowledge by means of genetic T cell-engineering to generate T cells that have superior anti-tumor activity.
Your task will include:
- Handling of primary human and murine immune cells
- Build on existing expertise to use and further develop CRISPR genome editing
- Using cellular methods (e.g., FACS) and functional assays (cytotoxicity assays, ELISA, chemotaxis experiments, imaging, etc.) to characterize immune cells
- Engineer T cells and test their functionality in advanced in vitro systems and/or murine disease models.
Requirements
We are looking for a highly motivated individual who is enthusiastic to work in an ambitious team on a competitive project, and who fits the following profile:
We are looking for a highly motivated individual who is enthusiastic to work in an ambitious team on a competitive project, and who fits the following profile:
- Strong interest in immunology & cancer
- Master in biology/biochemistry/molecular medicine or related fields
- Creative mind that is eager to shape the project and who wants to make an impact on immunological and biomedical research
- Experimental training in molecular biology and immunology
- Keen interest in using modern technology (i.e. CRISPR, T cell engineering, imaging, etc.)
- Excellent oral and written communication skills and team spirit
- Experience in mouse models (FELASA certificate) would be advantageous.
What we offer
Our lab offers the opportunity to work at the interface of immunology and cancer, which is one of the most exciting fields of recent biomedical research. We provide a dynamic and motivating working environment where you can foster your skills and get the opportunity to learn cutting-edge technologies such as CRISPR gene editing, T cell engineering, etc..
Our lab offers the opportunity to work at the interface of immunology and cancer, which is one of the most exciting fields of recent biomedical research. We provide a dynamic and motivating working environment where you can foster your skills and get the opportunity to learn cutting-edge technologies such as CRISPR gene editing, T cell engineering, etc..
- An international research environment that offers exciting and diverse opportunities
- Varied field of activity
- Flat hierarchies and short decision-making processes
- A highly motivated and cooperative team
- Individual development opportunities
- Flexible working hours
- Job ticket
The remuneration is based on TV-L.
Moreover, the LIT advocates for the compatibility of family and career.
Disabled applicants (m/f/d) with equal qualifications will receive preferential treatment within the recruitment procedure. Please refer to your disability status already in your application.
Please note that expenses that may arise in the context of an eventual job interview cannot be reimbursed.
For more information, please contact Prof. Philipp Beckhove (philipp.beckhove@ukr.de). We are looking forward to your detailed application.
Please apply via our homepage http://www.rcii.de quoting the reference PB-2023-1.
Application deadline is June 25th, 2023.
Moreover, the LIT advocates for the compatibility of family and career.
Disabled applicants (m/f/d) with equal qualifications will receive preferential treatment within the recruitment procedure. Please refer to your disability status already in your application.
Please note that expenses that may arise in the context of an eventual job interview cannot be reimbursed.
For more information, please contact Prof. Philipp Beckhove (philipp.beckhove@ukr.de). We are looking forward to your detailed application.
Please apply via our homepage http://www.rcii.de quoting the reference PB-2023-1.
Application deadline is June 25th, 2023.
Biologisch-technischen Assistenten m/w/d (PH-2023-1)
Das LIT – Leibniz-Institut für Immuntherapie (Stiftung des bürgerlichen Rechts) erforscht und entwickelt neue Immuntherapien zur Behandlung von Tumoren, Autoimmunerkrankungen und Transplantatabstoßungen.
Die Forschungsgruppe 'Immunregulation' (Leitung: PD Dr. Petra Hoffmann, LIT/Prof. Dr. Matthias Edinger, Klinik und Poliklinik für Innere Medizin III, UKR) beschäftigt sich mit zellulären Immunregulationsmechanismen nach allogener Knochenmarktransplantation. Zur Verstärkung unseres Teams suchen wir ab sofort einen
Die Forschungsgruppe 'Immunregulation' (Leitung: PD Dr. Petra Hoffmann, LIT/Prof. Dr. Matthias Edinger, Klinik und Poliklinik für Innere Medizin III, UKR) beschäftigt sich mit zellulären Immunregulationsmechanismen nach allogener Knochenmarktransplantation. Zur Verstärkung unseres Teams suchen wir ab sofort einen
Biologisch-technischen Assistenten m/w/d (PH-2023-1)
Kategorie: Wissenschaftliches Personal
Beschäftigungsverhältnis: Vollzeit
Gültig bis: 02.07.2023
in Vollzeit (40,1 Stunden pro Woche) und zunächst befristet auf zwei Jahre mit der Möglichkeit der Weiterbeschäftigung.
Ihre Aufgaben:
- Experimentelle Modelle der Knochenmarktransplantation (KMT)
- Gewebeaufarbeitung, Zellisolierungen, ELISA-Techniken
- Zellkultur-Techniken (Primärzellen und Zellinien)
- Molekularbiologische Analysen (qRT-PCR; PCR-basiertes Screening)
- Durchflusszytometrie inkl. FACS-basierte Zellsortierung
- Unterstützung von unterschiedlichen Forschungsprojekten
- Labor- und Bestellorganisation
Unsere Anforderungen:
- Abgeschlossene Berufsausbildung sowie Berufserfahrung als MTA/BTA/CTA/PTA
- Praktische Erfahrungen in Durchflusszytometrie
- Hohes Maß an Engagement, Eigenverantwortung, Zuverlässigkeit und Teamfähigkeit
Wir bieten Ihnen:
- Eine abwechslungsreiche und anspruchsvolle Aufgabe im dynamischen Umfeld von Medizin und Wissenschaft
- Flexible Arbeitszeiten zur Vereinbarkeit von Familie und Beruf
- Unterstützung bei der Wohnungssuche, Jobticket, Kinderbetreuung u.v.m.
Die Vergütung erfolgt nach TV-L.
Das LIT setzt sich besonders für die Vereinbarkeit von Familie und Beruf ein.
Schwerbehinderte (m/w/d) werden bei ansonsten im Wesentlichen gleicher Eignung bevorzugt eingestellt. Bitte weisen Sie auf eine vorliegende Schwerbehinderung in
der Bewerbung hin.
Bitte beachten Sie, dass wir Kosten, die bei einem etwaigen Vorstellungsgespräch für Sie anfallen sollten, nicht übernehmen können.
Bei Rückfragen wenden Sie sich bitte an Frau PD Dr. Petra Hoffmann (petra.hoffmann@ukr.de) oder Herrn Prof. Dr. Matthias Edinger (matthias.edinger@ukr.de).
Wir freuen uns auf Ihre aussagekräftige Bewerbung.
Bitte bewerben Sie sich über unsere Homepage www.rcii.de unter Nennung der Kennung PH-2023-1.bis 30.Juli 2023.
Das LIT setzt sich besonders für die Vereinbarkeit von Familie und Beruf ein.
Schwerbehinderte (m/w/d) werden bei ansonsten im Wesentlichen gleicher Eignung bevorzugt eingestellt. Bitte weisen Sie auf eine vorliegende Schwerbehinderung in
der Bewerbung hin.
Bitte beachten Sie, dass wir Kosten, die bei einem etwaigen Vorstellungsgespräch für Sie anfallen sollten, nicht übernehmen können.
Bei Rückfragen wenden Sie sich bitte an Frau PD Dr. Petra Hoffmann (petra.hoffmann@ukr.de) oder Herrn Prof. Dr. Matthias Edinger (matthias.edinger@ukr.de).
Wir freuen uns auf Ihre aussagekräftige Bewerbung.
Bitte bewerben Sie sich über unsere Homepage www.rcii.de unter Nennung der Kennung PH-2023-1.bis 30.Juli 2023.